Original Research
Published on 04 Sep 2024
A discovery and verification approach to pharmacovigilance using electronic healthcare data
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426323
- 826 views
Type at least 3 characters
396 articles
Articles
Original Research
Published on 29 Aug 2024
Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448319
- 1,617 views
Systematic Review
Published on 23 Aug 2024
Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1368274
- 811 views
Original Research
Published on 22 Aug 2024
Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1428210
- 1,201 views
Editorial
Published on 20 Aug 2024
Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1473052
- 706 views
Original Research
Published on 13 Aug 2024
A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392263
- 1,208 views
Original Research
Published on 13 Aug 2024
Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432759
- 1,884 views
- 1 citation
Systematic Review
Published on 31 Jul 2024
Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422773
- 1,000 views
Original Research
Published on 31 Jul 2024
The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382990
- 1,310 views
Original Research
Published on 26 Jul 2024
Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413944
- 2,753 views
Original Research
Published on 24 Jul 2024
Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411134
- 1,277 views
Review
Published on 24 Jul 2024
Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424606
- 1,686 views
Original Research
Published on 24 Jul 2024
Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403988
- 1,414 views
Original Research
Published on 22 Jul 2024
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362345
- 910 views
Original Research
Published on 19 Jul 2024
Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1371504
- 988 views
Original Research
Published on 12 Jul 2024
How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377232
- 715 views